Comparative Efficacy of Azathioprine versus Mycophenolate in Lung Transplant Recipients

被引：0
|
作者：
Olson, M. A. [1 ]
Bain, K. B. [1 ]
Fester, K. A. [1 ]
Chen, C. [2 ]
Hachem, R. R. [3 ]
机构：
[1] Barnes Jewish Hosp, Pharm, St Louis, MO 63110 USA
[2] UT Southwestern, Internal Med, Dallas, TX USA
[3] Washington Univ, Pulm & Crit Care Med, St Louis, MO USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2017年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
138
引用
收藏
页码：S61 / S62
页数：2
相关论文
共 50 条
  • [31] Pharmacokinetic predictors of treatment efficacy and adverse effects following mycophenolate therapy in lung transplant recipients.
    Tsang, S
    Ting, LSL
    Partovi, N
    Levy, RD
    Ensom, MHH
    PHARMACOTHERAPY, 2005, 25 (10): : 1490 - 1490
  • [32] Immunoglobulin deficiency in kidney allograft recipients: comparative effects of mycophenolate mofetil and azathioprine.
    Keven, K
    Sahin, M
    Kutlay, S
    Sengul, S
    Erturk, S
    Erbay, B
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 646A - 646A
  • [33] Cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion
    Thervet, E
    Morelon, E
    Ducloux, D
    Bererhi, L
    Noël, LH
    Bedrossian, JJ
    Puget, S
    Chalopin, JM
    Mihatsch, M
    Legendre, C
    Kreis, H
    CLINICAL TRANSPLANTATION, 2000, 14 (06) : 561 - 566
  • [34] Improved rejection free survival with adjunctive mycophenolate vs azathioprine in pediatric heart transplant recipients
    Morrow, W. R.
    Naftel, D. C.
    Edens, E. E.
    Lamour, J. M.
    Canter, C.
    Parker, J.
    Ainley, K.
    Kajevska, I.
    Myers, S.
    Kirklin, J. K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S85 - S85
  • [35] Safe conversion of mycophenolate mofetil to azathioprine in kidney transplant recipients with sirolimus-based immunosuppression
    El-Agroudy, Amgad E.
    El-Dahshan, Khaled F.
    Wafa, Ehab W.
    Sheashaa, Hussien A.
    Gad, Ziad A.
    Ismail, Amani M.
    Shokeir, Ahmed A.
    Ghoneim, Mohamed A.
    NEPHROLOGY, 2009, 14 (02) : 255 - 261
  • [36] Effects of azathioprine and mycophenolate mofetil-immunosuppressive regimens on the erythropoietic system of renal transplant recipients
    Khosroshahi, H. T.
    Asghari, A.
    Estakhr, R.
    Baiaz, B.
    Ardalan, M. R.
    Shoja, M. M.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (07) : 2077 - 2079
  • [37] Effects of azathioprine and mycophenolate mofetil based immunosuppressive regimen on the erthropoietic system of the renal transplant recipients
    Khosroshahi, Hamid Tayebi
    Estakhri, Rassul
    shoja, Mahamadali Mohajel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 263 - 263
  • [38] Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients
    Wagner, Martin
    Earley, Amy K.
    Webster, Angela C.
    Schmid, Christopher H.
    Balk, Ethan M.
    Uhlig, Katrin
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (12):
  • [39] Therapeutic equivalence of mycophenolate sodium versus mycophenolate mofetil in de novo renal transplant recipients
    Salvadori, M
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3245 - 3247
  • [40] Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients
    Eisen, HJ
    Kobashigawa, J
    Keogh, A
    Bourge, R
    Renlund, D
    Mentzer, R
    Alderman, E
    Valantine, H
    Dureau, G
    Mancini, D
    Mamelok, R
    Gordon, R
    Wang, WD
    Mehra, M
    Constanzo, MR
    Hummel, M
    Johnson, J
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (05): : 517 - 525
12345